Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

High-Yield Pearls for Management of Warts with Therapeutic Updates

Description

The presentation discusses various treatment options for managing warts, emphasizing the need for tailored approaches based on patient characteristics and wart presentation. Most warts tend to resolve spontaneously, particularly those present for less than two years. The discussion highlights the limited but significant evidence from a Cochrane review favoring salicylic acid and cryotherapy, while also noting that cryotherapy might not be ideal for painful plantar warts. Various topical treatments like imiquimod and vitamin D are covered, though many lack comprehensive studies. The presentation explores emerging therapies, including Burdasmer gel and other antiviral compounds, along with the potential use of intralesional therapies for tougher cases. The role of the HPV vaccine is also discussed, particularly for patients under 26, as it shows promise in wart clearance. Procedural updates include therapies such as photodynamic therapy and microwave treatment, which have shown efficacy but are often costly. The document concludes by underscoring the necessity of combination therapies and the importance of patient-centered decision-making in wart management, given the diverse treatment landscape and limited high-quality data.

View more

Conclusions

  • Most warts, especially new ones, tend to spontaneously resolve.
  • Warts that persist for more than two years are less likely to respond to treatment.
  • Salicylic acid is considered safe and has modest efficacy for treating warts.
  • Cryotherapy may be effective in cases where salicylic acid has failed or in combination with it.
  • Intralesional treatments demonstrate equal or greater efficacy compared to first-line treatments like salicylic acid or cryotherapy, especially for refractory cases.
  • Cryotherapy can have painful side effects, especially for plantar warts, where no trials have shown it to be better than placebo.
  • Topical vitamin D can be beneficial for patients concerned about dyspigmentation, although some other treatments may be more effective.
  • Topical cidofovir has shown potential benefits but lacks large-scale studies for common warts and can be costly.
  • Combination therapies, such as microneedling with topical agents, may enhance treatment efficacy and reduce the number of sessions needed.
  • New treatment options, such as berdazimer gel and ionic antiviral therapy, are currently in development and may soon be available.
  • Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No: CD001781. DOI: 10.1002/14651858.CD001781.pub3. Accessed 05 February 2024.
  • Clifton MM, Johnson SM, Roberson PK, Kincannon J, Horn TD. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens. Pediatric dermatology. 2003 May;20(3):268-71.
  • Friedman PC. Management of difficult-to-treat warts: traditional and new approaches. American journal of clinical dermatology. 2021 May;22(3):379-94.
  • Shalaby ME, Hasan MS, Elshorbagy MS, Abo Raya AR, Elsaie ML. Diagnostic and therapeutic implications of vitamin D deficiency in patients with warts: a case-controlled study. Journal of Cosmetic Dermatology. 2022 Mar;21(3):1135-42.
  • Nickles MA, Sergeyenko A, Bain M. Treatment of warts with topical cidofovir in a pediatric patient. Dermatol Online J. 2019 May 15;25(5):13030/qt5sq5b24g. PMID: 31220896.
  • Bacelieri R, Johnson SM. Cutaneous warts: an evidence-based approach to therapy. Am Fam Physician. 2005 Aug 15;72(4):647-52. PMID: 16127954.
  • Kazeminejad A, Bodaghi A, Hajheydari Z, Moosazadeh M, Rafati M, Gholizadeh N. Topical Calcipotriol for the Treatment of Cutaneous Warts: An Assessor-Blind Randomized Placebo-Controlled Trial. Dermatologic Therapy. 2023 Feb 16;2023.
  • Berumen-Glinz C, de la Barreda-Becerril F. Treatment of Verruca Plana With Topical Combination of Calcipotriol and Fluorouracil. JAMA Dermatol. 2022;158(5):586-587. doi:10.1001/jamadermatol.2022.0154.
  • Tyring SK, Rosen T, Berman B, et al. A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment. Journal of Drugs in Dermatology : JDD. 2018 Oct;17(10):1100-1105. PMID: 30365591.
  • Cusini M, Micali G, Lacarrubba F, et al. Efficacy and tolerability of nitric-zinc complex in the treatment of external genital warts and "difficult-to-treat" warts: a "proof of concept", prospective, multicentre, open study. Giornale Italiano di Dermatologia e Venereologia : Organo Ufficiale, Societa Italiana di Dermatologia e Sifilografia. 2015 Dec;150(6):643-648. PMID: 26513041.
  • Rijsbergen M, Niemeyer-van der Kolk T, Hogendoorn G, Kouwenhoven S, Lemoine C, Klaassen ES, de Koning M, Beck S, Bouwes Bavinck JN, Feiss G, Burggraaf J. A randomized controlled proof-of-concept trial of digoxin and furosemide in adults with cutaneous warts. British Journal of Dermatology. 2019 May 1;180(5):1058-68.
  • Shen S, Feng J, Song X, Xiang W. Efficacy of photodynamic therapy for warts induced by human papilloma virus infection: A systematic review and meta-analysis. Photodiagnosis and Photodynamic Therapy. 2022 Sep 1;39:102913.
  • Stender IM, Na R, Fogh H, Gluud C, Wulf HC. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. The Lancet. 2000 Mar 18;355(9208):963-6.
  • Hagon W, Hagon J, Noble G, et al. Microwave therapy for the treatment of plantar warts. J Foot Ankle Res 16, 37 (2023). https://doi.org/10.1186/s13047-023-00638-8.